News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,595 Results
Type
Article (42589)
Company Profile (308)
Press Release (700683)
Multimedia
Podcasts (97)
Webinars (20)
Section
Business (207631)
Career Advice (2073)
Deals (35923)
Drug Delivery (135)
Drug Development (82438)
Employer Resources (175)
FDA (16572)
Job Trends (15172)
News (351034)
Policy (33046)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2632)
Accelerated approval (53)
ADA (43)
Adcomms (27)
Allergies (181)
Alliances (50473)
ALS (222)
Alzheimer's disease (1826)
Antibody-drug conjugate (ADC) (497)
Approvals (16998)
Artificial intelligence (707)
ASCO (330)
Autoimmune disease (326)
Automation (59)
Bankruptcy (365)
Best Places to Work (11707)
BIOSECURE Act (21)
Biosimilars (229)
Biotechnology (207)
Bladder cancer (200)
Brain cancer (73)
Breast cancer (788)
Cancer (6159)
Cardiovascular disease (488)
Career advice (1765)
Career pathing (44)
CAR-T (352)
CDC (57)
Celiac Disease (3)
Cell therapy (954)
Cervical cancer (51)
Clinical research (71936)
Collaboration (2166)
Company closure (5)
Compensation (1466)
Complete response letters (82)
COVID-19 (2777)
CRISPR (115)
C-suite (1202)
Cystic fibrosis (155)
Data (8453)
Decentralized trials (3)
Denatured (28)
Depression (170)
Dermatology (93)
Diabetes (646)
Diagnostics (7030)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (341)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (293)
Earnings (92730)
Editorial (68)
Employer branding (21)
Employer resources (154)
Events (123361)
Executive appointments (1121)
FDA (20455)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1804)
Gene editing (245)
Generative AI (63)
Gene therapy (755)
GLP-1 (1086)
Government (4769)
Grass and pollen (6)
Guidances (414)
Healthcare (19232)
Hematology (194)
HIV (83)
Huntington's disease (59)
IgA nephropathy (110)
Immunology and inflammation (293)
Immuno-oncology (102)
Indications (203)
Infectious disease (3133)
Inflammatory bowel disease (219)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (309)
Interviews (324)
IPO (16787)
IRA (50)
Job creations (3765)
Job search strategy (1464)
JPM (58)
Kidney cancer (20)
Labor market (107)
Layoffs (570)
Leadership (42)
Legal (8028)
Liver cancer (102)
Longevity (35)
Lung cancer (819)
Lymphoma (453)
Machine learning (63)
Management (59)
Manufacturing (1106)
MASH (202)
Medical device (13981)
Medtech (14125)
Mergers & acquisitions (20413)
Metabolic disorders (1607)
mRNA (219)
Multiple sclerosis (195)
NASH (17)
Neurodegenerative disease (444)
Neuropsychiatric disorders (107)
Neuroscience (3418)
Neurotech (1)
NextGen: Class of 2026 (6595)
Non-profit (4564)
Now hiring (79)
Obesity (742)
Opinion (303)
Ovarian cancer (233)
Pain (260)
Pancreatic cancer (335)
Parkinson's disease (385)
Partnered (33)
Patents (619)
Patient recruitment (713)
Peanut (66)
People (60833)
Pharmaceutical (62)
Pharmacy benefit managers (33)
Phase 1 (22518)
Phase 2 (31735)
Phase 3 (23459)
Pipeline (9388)
Policy (326)
Postmarket research (2578)
Preclinical (9607)
Press Release (71)
Prostate cancer (326)
Psychedelics (54)
Radiopharmaceuticals (339)
Rare diseases (1130)
Real estate (6138)
Recruiting (72)
Regulatory (25816)
Reports (57)
Research institute (2452)
Resumes & cover letters (359)
Rett syndrome (41)
RNA editing (23)
RSV (88)
Schizophrenia (181)
Series A (306)
Series B (224)
Service/supplier (11)
Sickle cell disease (122)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3753)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (89)
The Weekly (67)
Vaccines (1127)
Venture capital (117)
Weight loss (475)
Women's health (132)
Worklife (20)
Date
Today (164)
Last 7 days (724)
Last 30 days (3059)
Last 365 days (30770)
2026 (14744)
2025 (30607)
2024 (35627)
2023 (40427)
2022 (51638)
2021 (56107)
2020 (54477)
2019 (46906)
2018 (35344)
2017 (32523)
2016 (32052)
2015 (38031)
2014 (31812)
2013 (26847)
2012 (29162)
2011 (29834)
2010 (27936)
Location
Africa (771)
Alabama (93)
Alaska (7)
Arizona (357)
Arkansas (15)
Asia (40799)
Australia (6818)
California (13853)
Canada (3875)
China (1454)
Colorado (587)
Connecticut (607)
Delaware (425)
Europe (89021)
Florida (2050)
Georgia (442)
Hawaii (3)
Idaho (63)
Illinois (1134)
India (93)
Indiana (622)
Iowa (24)
Japan (567)
Kansas (136)
Kentucky (51)
Louisiana (56)
Maine (76)
Maryland (1642)
Massachusetts (9932)
Michigan (372)
Minnesota (743)
Mississippi (6)
Missouri (146)
Montana (36)
Nebraska (29)
Nevada (145)
New Hampshire (85)
New Jersey (3618)
New Mexico (31)
New York (3624)
North Carolina (1767)
North Dakota (10)
Northern California (6987)
Ohio (410)
Oklahoma (23)
Oregon (41)
Pennsylvania (2759)
Puerto Rico (29)
Rhode Island (51)
South America (1153)
South Carolina (86)
South Dakota (2)
Southern California (5467)
Tennessee (218)
Texas (2203)
United States (48815)
Utah (413)
Vermont (1)
Virginia (334)
Washington D.C. (81)
Washington State (1119)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
743,595 Results for "plandai biotechnology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Plandai Biotechnology, Inc. Announces Rescission of Material Definitive Agreement with Good Salt, LLC
Plandai Biotechnology, Inc. announces the rescission of a material definitive agreement with Good Salt, LLC due to the material failure of consideration in the transaction.
August 1, 2023
·
1 min read
Business
Plandai Biotechnology, Inc. Announces Entry into Material Share Exchange Agreement with Good Salt, LLC
Plandai Biotechnology, Inc. (OTC PINK:PLPL) announces it has entered into a binding memorandum of understanding to close a share exchange agreement with Good Salt, LLC, a Florida limited liability company.
March 20, 2023
·
4 min read
Deals
Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit
Plandai Biotechnology, Inc. announces the termination of its previously announced asset acquisition agreement with EV Hotel Corp., a Georgia corporation.
January 4, 2023
·
1 min read
BioMidwest
ByoPlanet Announces Completion of Share Exchange Agreement with Plandai Biotechnology
Plandai Biotechnology, Inc. announce the completion of a share exchange agreement whereby PLPL shall acquire one hundred percent of the issued and outstanding ByoPlanet Interests and ByoPlanet’s fixed tangible and intangible assets in exchange for all authorized, issued, and outstanding PLPL Preferred Common Shares and Common Stock.
May 17, 2023
·
5 min read
Policy
Plandai Biotechnologies, Inc. Announces Entry into Non-Binding Letter of Intent, Updates on Status of Independent Audit
Plandai Biotechnology, Inc. announces its entry into a non-binding letter of intent with EV Hotel Corp., a Georgia corporation.
October 6, 2022
·
3 min read
Business
Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
Plandai Biotechnology, Inc. announces the termination of its non-binding letter of intent dated May 23, 2022, with Ms. Jessie Chiang, license holder of the worldwide rights, exclusive of Taiwan, of the Puriblood Leukocyte Reduction Blood Filtration System.
July 27, 2022
·
1 min read
Press Releases
Sana Biotechnology to Present at June 2026 Investor Conferences
May 27, 2026
·
3 min read
Press Releases
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
June 3, 2026
·
4 min read
Press Releases
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. announce the successful delivery of a seasonal influenza vaccine in development - February 10, 2026
February 11, 2026
·
3 min read
Press Releases
POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding
June 4, 2026
·
6 min read
1 of 74,360
Next